Kura Oncology (KURA) had its price target lowered by Mizuho from $30.00 to $25.00. They now have an "outperform" rating on the stock.
Kura Oncology (KURA) had its "buy" rating reaffirmed by UBS Group AG.
Kura Oncology, Inc. (KURA) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]
How The Kura Oncology (KURA) Story Is Shifting With Komzifti And New Street Targets [Yahoo! Finance]
Kura Oncology (KURA) had its price target lowered by Wedbush from $38.00 to $36.00. They now have an "outperform" rating on the stock.